CHEMOMAB THERAPEUTICS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.68 USD | -2.86% |
|
-11.67% | +33.33% |
| Apr. 10 | Transcript : Chemomab Therapeutics Ltd. - Special Call | |
| Mar. 07 | Chemomab Therapeutics Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Chart calendar Chemomab Therapeutics Ltd.
7aab848e6438ed4d.j8QyvD6JMVkZ7S8daIMPfADDwkB2kwq_FsUYiqOu1fk.-6ULiXnMWRtXn3d_HbVrUTaCrHJb0ViOW7xU8_vgnKG-jEPNVt5zNUyseg~4baee471fe2d5012ccd0be7ce61419af
Upcoming events on Chemomab Therapeutics Ltd.
Past events on Chemomab Therapeutics Ltd.
| 2024-04-10 10:00 am | Investor Meeting - Key Opinion Leader |
| 2024-03-12 10:40 am | Leerink Partners Global BioPharma Conference |
| 2024-03-07 07:00 am | Q4 2023 Earnings Release |
| 2024-02-14 08:00 am | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-15 | American College of Rheumatology Convergence |
| 2023-11-14 12:00 pm | American College of Rheumatology Conference |
| 2023-11-13 04:30 pm | AASLD Liver Meeting |
| 2023-11-11 01:00 pm | AASLD Liver Meeting |
| 2023-11-09 08:00 am | Q3 2023 Earnings Release |
| 2023-10-12 12:00 pm | Roth Healtcare Opportunities Conference |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 08:00 am | Q2 2023 Earnings Release |
| 2023-06-23 03:00 am | European Association for the Study of the Liver Congress - Abstract No. #2178 |
| 2023-06-22 03:00 am | European Association for the Study of the Liver Congress |
| 2023-06-21 03:00 am | European Association for the Study of the Liver Congress - Poster No. -Late-Breaker, LBP-28 |
| 2023-06-04 | BIO International Convention |
| 2023-06-02 08:45 am | EULAR Congress |
| 2023-05-12 11:20 am | EASL Monothematic Conference |
| 2023-05-11 08:00 am | Q1 2023 Earnings Call |
| 2023-05-11 06:00 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -12,4 -10,8 -14.92% | -28,5 -28,6 0.39% | -25,5 -26,0 1.97% | -15,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -12,5 -10,8 -15.31% | -28,2 -28,6 1.63% | -24,2 -25,0 3% | -15,5 |
|
Net income Million USD | Released Forecast Spread | -5,95 | -12,5 -10,8 -15.31% | -27,6 -28,4 2.64% | -24,2 -25,1 3.36% | -15,7 |
|
EPS USD | Released Forecast Spread | 0,00 | -0,06 -0,04 -50% | -0,12 -0,12 -5.22% | -0,10 -0,11 6.36% | -0,06 |
| Announcement Date | 19/03/21 | 09/03/22 | 21/02/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,02 -3,43 -46.34% | -5,32 -5,17 -2.87% | -6,25 -5,76 -8.59% | -8,32 -6,52 -27.49% | -8,64 -8,75 1.23% | -9,05 -9,40 3.73% | -8,20 -9,10 9.95% | -4,37 -5,00 12.66% | -3,85 -4,36 11.72% | -3,92 | -3,94 | -4,00 | -4,03 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,04 -3,78 -33.4% | -5,10 -5,50 7.2% | -6,73 -5,75 -17.11% | -8,08 -6,40 -26.25% | -8,26 -8,75 5.58% | -8,73 -9,40 7.11% | -7,94 -8,83 10.07% | -4,14 -4,75 12.93% | -3,42 -4,17 18% | -3,75 | -3,75 | -4,00 | -4,00 |
|
Net income Million USD | Released Forecast Spread | -5,04 -3,40 -48.07% | -5,10 -5,41 5.72% | -6,19 -5,69 -8.86% | -8,08 -6,69 -20.84% | -8,27 -8,75 5.46% | -8,75 -9,40 6.88% | -7,97 -8,83 9.69% | -4,08 -4,75 14.08% | -3,42 -4,26 19.77% | -3,82 | -3,84 | -4,00 | -4,03 |
|
EPS USD | Released Forecast Spread | -0,02 -0,02 -10% | -0,02 -0,25 91.02% | -0,03 -0,18 85% | -0,04 -0,23 84.78% | -0,04 -0,03 -20% | -0,04 -0,04 -14.29% | -0,04 -0,04 10% | -0,02 -0,02 15% | -0,01 -0,02 35% | -0,02 | -0,02 | -0,02 | -0,02 |
| Announcement Date | 09/03/22 | 12/05/22 | 12/08/22 | 10/11/22 | 21/02/23 | 11/05/23 | 14/08/23 | 09/11/23 | 07/03/24 | - | - | - | - |
More events
Past sector events for Chemomab Therapeutics Ltd.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CMMB Stock
- Calendar Chemomab Therapeutics Ltd.
